Literature DB >> 30505475

Conventional MRI to detect the differences between mass-like tuberculosis and lung cancer.

Li-Ping Qi1, Ke-Neng Chen2, Xiaohong Joe Zhou3, Lei Tang1, Yu-Liang Liu1, Xiao-Ting Li1, Juan Wang1, Ying-Shi Sun1.   

Abstract

BACKGROUND: The aim of this study was to investigate differences in the imaging features of mass-like tuberculosis and lung cancer on conventional MR sequences to improve the diagnostic ability for pulmonary masses.
METHODS: Thirty patients with suspicious pulmonary lesions were enrolled and diagnosed with tuberculosis by pathology or comprehensive clinical diagnoses. Twenty-six cases of lung cancer were retrospectively analyzed. Transverse fat-suppressed T2-weighted (T2W) imaging and T1-weighted (T1W) imaging were obtained at 1.5 Tesla. The imaging characteristics of lesions on the T2W and T1W images were compared between the two groups. The imaging features of enlarged mediastinal lymph nodes on T2W images were studied and compared.
RESULTS: On T2W images, there was a higher percentage of lesions containing hypointensity in the tuberculosis group (GTB) than in the lung cancer group (GLC) (P=0.004).The incidence of lesions demonstrating heterogeneous intensity was significantly greater in the GTB than in the GLC (70.0% vs. 7.7%, P=0.001). Approximately 92.3% of the lung cancer cases showed hyperintensity, a proportion substantially greater than that in the GTB (6.7%). On T1W images, more cases showed hyperintensity in the GTB than in the GLC (43.3% vs. 7.7%, P=0.003). The signal intensity ratios (SIRs) of the lesion to rhomboid muscle on T2W and T1W images were significantly different between the two groups. The mean intrasubject standard deviation (SD) of lesions in the GTB was markedly greater than that in the GLC on both T2W and T1W images. Benign mediastinal lymph nodes in the GTB showed a variety of signals on T2W images, whereas 80% of metastatic mediastinal lymph nodes displayed slight homogeneous hyperintensity, and this difference between the two groups was statistically significant.
CONCLUSIONS: Conventional MR sequences can reveal the essential differences between mass-like tuberculosis and lung cancer and may be helpful for discriminating pulmonary masses.

Entities:  

Keywords:  Tuberculosis; differential diagnosis; lung neoplasm; magnetic resonance imaging

Year:  2018        PMID: 30505475      PMCID: PMC6236172          DOI: 10.21037/jtd.2018.09.125

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  26 in total

1.  Thin-rim enhancement in Gd-DTPA-enhanced magnetic resonance images of tuberculoma: a new finding of potential differential diagnostic importance.

Authors:  F Sakai; S Sone; A Maruyama; T Kawai; S Imai; J Aoki; M Morimoto; M Haniuda; H Ueda; T Honda
Journal:  J Thorac Imaging       Date:  1992-06       Impact factor: 3.000

2.  Abdominal MRI at 3.0 T: LAVA-Flex compared with conventional fat suppression T1-weighted images.

Authors:  Xing Hui Li; Jiang Zhu; Xiao Ming Zhang; Yi Fan Ji; Tian Wu Chen; Xiao Hua Huang; Lin Yang; Nan Lin Zeng
Journal:  J Magn Reson Imaging       Date:  2013-11-12       Impact factor: 4.813

3.  Mediastinal nodes in patients with non-small cell lung cancer: MRI findings with PET/CT and pathologic correlation.

Authors:  Dae Wook Yeh; Kyung Soo Lee; Joungho Han; Chin A Yi; Ho Yun Lee; Myung Jin Chung; Tae Sung Kim
Journal:  AJR Am J Roentgenol       Date:  2009-09       Impact factor: 3.959

4.  Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis.

Authors:  Guohua Shen; Zhiyun Jia; Houfu Deng
Journal:  Eur Radiol       Date:  2015-05-24       Impact factor: 5.315

5.  Lung nodule enhancement at CT: multicenter study.

Authors:  S J Swensen; R W Viggiano; D E Midthun; N L Müller; A Sherrick; K Yamashita; D P Naidich; E F Patz; T E Hartman; J R Muhm; A L Weaver
Journal:  Radiology       Date:  2000-01       Impact factor: 11.105

Review 6.  The magnetic resonance imaging of infections and inflammatory diseases.

Authors:  G Sze; R D Zimmerman
Journal:  Radiol Clin North Am       Date:  1988-07       Impact factor: 2.303

7.  Mediastinal tuberculous lymphadenitis: MR imaging appearance with clinicopathologic correlation.

Authors:  W K Moon; J G Im; I K Yu; S K Lee; K M Yeon; M C Han
Journal:  AJR Am J Roentgenol       Date:  1996-01       Impact factor: 3.959

8.  Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging.

Authors:  Yoshiharu Ohno; Hiroto Hatabu; Daisuke Takenaka; Takanori Higashino; Hirokazu Watanabe; Chiho Ohbayashi; Masahiro Yoshimura; Miyako Satouchi; Yoshihiro Nishimura; Kazuro Sugimura
Journal:  Radiology       Date:  2004-06       Impact factor: 11.105

9.  MRI of the lung (2/3). Why … when … how?

Authors:  J Biederer; M Beer; W Hirsch; J Wild; M Fabel; M Puderbach; E J R Van Beek
Journal:  Insights Imaging       Date:  2012-02-13

Review 10.  Usefulness of contrast-enhanced magnetic resonance imaging for evaluating solitary pulmonary nodules.

Authors:  Kiminori Fujimoto
Journal:  Cancer Imaging       Date:  2008-03-03       Impact factor: 3.909

View more
  3 in total

1.  Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients.

Authors:  Wen Shi; Juan Wu; Qi Tan; Chun-Mei Hu; Xia Zhang; Hong-Qiu Pan; Zhen Yang; Meng-Yu He; Min Yu; Bo Zhang; Wei-Ping Xie; Hong Wang
Journal:  Infect Drug Resist       Date:  2019-05-14       Impact factor: 4.003

2.  Value of 18F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With 18F-FDG PET/CT, MRI, and Contrast-Enhanced CT.

Authors:  Fei Wang; Rui Guo; Yan Zhang; Boqi Yu; Xiangxi Meng; Hanjing Kong; Yang Yang; Zhi Yang; Nan Li
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

3.  Combination Assessment of Diffusion-Weighted Imaging and T2-Weighted Imaging Is Acceptable for the Differential Diagnosis of Lung Cancer from Benign Pulmonary Nodules and Masses.

Authors:  Katsuo Usuda; Masahito Ishikawa; Shun Iwai; Yoshihito Iijima; Nozomu Motono; Munetaka Matoba; Mariko Doai; Keiya Hirata; Hidetaka Uramoto
Journal:  Cancers (Basel)       Date:  2021-03-28       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.